LivaNova PLC (LIVN) Financials
LIVN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 2.4 billion | 1.2 billion |
| 2023-09-30 | 2.3 billion | 1.1 billion |
| 2023-06-30 | 2.3 billion | 1.1 billion |
| 2023-03-31 | 2.3 billion | 1.1 billion |
LIVN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 41.0 million | 8.3 million |
| 2023-09-30 | 9.4 million | 11.8 million |
| 2023-06-30 | -23.6 million | 5.7 million |
| 2023-03-31 | 13.1 million | 10.6 million |
LIVN Net Income
No data available :(
LIVN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 577.9 million | - | 53.8 million |
| 2023-09-30 | 233.9 million | - | 25.2 million |
| 2023-06-30 | 222.9 million | 568.0 million | 27.2 million |
| 2023-03-31 | 214.3 million | 520.2 million | 28.8 million |
LIVN Shares Outstanding
LIVN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 12.9 million | 46.2 million | 133.3 million | - |
| 2023-09-30 | 8.8 million | 46.5 million | 134.8 million | - |
| 2023-06-30 | 5.6 million | 51.1 million | 125.9 million | - |
| 2023-03-31 | 7.7 million | 50.0 million | 124.1 million | - |
LIVN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 310.1 million | 119.9 million |
| 2023-09-30 | 286.1 million | 84.3 million |
| 2023-06-30 | 293.9 million | 88.7 million |
| 2023-03-31 | 263.4 million | 89.3 million |
LIVN
Price: $62.92
52 week price:
Earnings Per Share: 0.32 USD
P/E Ratio: 994.20
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 315000
Ebitda: 55.0 millionMarket Capitalization: 2.9 billion